Shuang Dai, Shuang Dai, Shuang Dai, Yuanliang Yan, Yuanliang Yan, Zhijie Xu, . . . Zhicheng Gong. (2018). SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-Catenin Signaling Axis. Frontiers Media S.A..
Chicago Style (17th ed.) CitationShuang Dai, et al. SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-Catenin Signaling Axis. Frontiers Media S.A., 2018.
MLA (9th ed.) CitationShuang Dai, et al. SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-Catenin Signaling Axis. Frontiers Media S.A., 2018.
Warning: These citations may not always be 100% accurate.